Company Export Data of India History Records | India Exporter History Records Company of M S Glenmark Pharmaceuticals Ltd Data

PHARMACEUTICALS

PHARMACEUTICALS

PHARMACEUTICALS

1X40 RH PART OF FCL SAID TO CONTAIN 517 CARTOEUTICALS AS UNDER MOMETASONE FUROATE OINTMENT0.1 15GM NDC CODE68462022517 FDA PROD

PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPSPRODUCT CODE NO. 65 R C F 14 H. T. S NO. 3 004.90.92.90 3004.90.92.30 3004.90.

PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPSPRODUCT CODE NO.65 R C F 14 H. T. S NO. 30 04.90.92.90 3004.90.92.20

14 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER ESOM EPRAZOLE MAG DR CAPS 20MG 90 S NDC CODE:68462039090 FDA PR ODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 A NDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL H YPERSECRETORY CONDITIONS, INC LUDING ZOLLINGER-ELLISON SYN DROME ESOMEPRAZOLE MAG DR C APS 40MG 90 S NDC CODE:684620 39190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004 .90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOL E MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR T HE LONG-TERM TREATMENT OF PA THOLOGICAL HYPERSECRETORY CO NDITIONS, INCLUDING ZOLLINGER -ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7000139 DT. 29.04.2022 S/BILL NO: 4006221 DT: 29/04/2022 NET WT: 756.17 KGS 14 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

01 X 40 RF CNTR TOTAL 41 (FORTY ONE) PACKAGESTS 500MG 500 S NDC CODE68462019005 FDA PRODU CT CODE NO.-62 G C A 49 H. T. S NO.

1X40 REF 3858 CARTONS PACKED IN 46 PALLETS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC PRAMIPEXOLE TABS 1M G 90 S NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S DI SEASE PRAMIPEXOLE TABS 0.25MG 90 S NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DIS EASE OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AGE NT OLMESARTAN MEDOXOMIL TABLE TS 5MG 30 S NDC CODE:68462043 630 FDA PRODUCT CODE NO.: 62C CA68 H. T. S NO.: 3004.90.922 0 ANDA NO.: 203281 THERAPEUTI CE USE: -TREATMENT OF HYPERTEN SION, ALONE ORWITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S N DC CODE:68462047205 FDA PRODU CT CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA NO. : 206391 THERAPEUTICE USE: - MEDICATION USED FOR HEART FAIL URE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART URSODIOL TABS 2 50MG 100 S NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 90-801 THERA PEUTICE USE: - FOR THE TREATME NT OF PATIENTS WITH PRIMARY B ILIARY CIRRHOSIS GABAPENTIN TABLETS 600MG 100 S NDC CODE: 68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICON VULSANT AGENT NET WT : 10,381 .95 KGS GROSS WT : 12,463.41 KGS COMMERCIAL & CUSTOM INVOI CE NO. F22252005778 DT. 23.02 .2022 F22252005780 DT. 23.02. 2022 SB NO.: 8492215 DT.: 24/ 02/22 SB NO.: 8492102 DT.: 24 /02/22 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES

1 X 40 FCL REEFER 49 PACKAGE CONSISTING OF 3295 CARTONS PH ARMACEUTICALS AS UNDER NAPROX EN TABLETS 500MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLET S 25MG 60 S NDC CODE:68462010 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT GABAPENTIN TABLETS 600MG 5 00 S NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.:91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE 03 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F222520055 51 DT. 05.02.2022 F2225200555 2 DT. 05.02.2022 F22252005553 DT. 05.02.2022 TOTAL NET.WT. :11610.44KGS SBILL NOS DT. 8053058 07-FEB-2022 80532 61 07-FEB-2022 8053408 07- FEB-2022